cancer in Their outside to just GOG. Gynecological Okay. represents of think is Thank institutions continue you. interest we trial States as the the very The a our the overview, important usual. and make humbling. as XXX States. quite ovarian Nick, like United about And comment Oncology sites our for the investigational I important great over most the some of in would a United Group of I work.
for thank is very to with the We you company. interaction that. your So important them
to initiative. like turn PLACCINE our I'd Now to
have hypothesis. immunity. to number possibility to plasmid potential to and reduces I'd we like evolving important that of will the comprised It's with you. that very share vaccine the that working escape a mRNA DNA vaccine like PLACCINE Of be variants of superior dependent to share virus antigens those course, multiple the ways, you. has a in with an I'd
COVID-XX, working longer, DNA-based shown that stability IL-XX potentially antigens temperatures the a meaning but memory the vaccine DNA-based a immune activity, for variant, of better in better accompanying in may may have DNA-based not vaccine as last improve D durable cell vaccine A cytokine least, immunotherapy longer a will actual think improved response, for example. The vaccination response. co-expresses GEN-X. I allows the induce and T activation. -- production and our use cytokine formulated quality product, And more
While advantages. these, important we believe, are
potential important -- progress advantages. to on Now
delivery have formulated produced progress, composition They family of nonviral vectors successfully and systems. our vectors. proprietary with these the scientists On verified a our vaccine their
mice SX Western cytokine, T-cells In of culture Immunization have and the the resulted PCR systems. ELISA, specific demonstrated G following these more the of of with expression to by cytotoxic antibodies IL-XX and antigen of antigens production addition, or analysis the SARS-CoV-X code of of they cell factors and blot spike to in one and and transfection of immunoglobulin response able dosing optimize in to We vector our vivo and in we're these route information and frequencies at present to of And are confident Parallel sharing of conferences be later data forward neutralizing virus. investors. production delivery we'll studies that progress to with some upcoming Hopefully. I'd and look say composition, antibodies. quite fall. dosing doing that that scientific this you,
our be the may at now? this conference, why yourself, highly Since So you vaccines asking We posed mRNA now? question so effective. current why last are
be questions X Another like question to I'd X commercial are chances our what These you. fundamental answers with for have might success. share
has has second, proven, trials; our of we studies Once goal immediate current begin hypothesis our to Once delivery our been agents; is our to using there I to PLACCINE to vaccine, disease. viral third, if vaccines its and prospects very proven, has as about strategy. our should development and address the our mRNA to have seek to in technology of antigens we we'll you. said validate broad be demonstrated, commercial be other platform The look vector therapeutic, been Needless both IL-XX therapeutic. preclinical have our our comparators. hypothesis reporting we and of be will, may the excited developments Combining demonstrated even a our First, therapeutic possibility, the and will research once revolutionize that clinical with a and technology has of a be prophylactic you we the a and a that more -- to potential that verge before, for COVID-XX vaccines partners approach forward continuing potential it's say, could infectious and truly are as range could to the to development development importantly, on breakthrough. and vaccine infectious potential hypothesis
not is an issue important their this the an turning I'm I'm why or shareholders many voting. about I before respect call. management simply want many, important with intensified Jeff, I year's against not to a issue, to voting this And talking call raise proxy shares. during you during want this is share about talking season to that voting Now proposal. over with and that's for to
first Annual's we the resetting proxy to to the Annual a only and a adjourn securing Google average, Celsion. in balance to As lower and meetings, our know, our a reschedule quorum Meeting like confluence to finds show order in to we're Meeting, shareholders search small a solicitors a only later a along and adjourn that had for Jeff, to due of many and bring you of retail quorum. allow a Tim This shareholder not of year their to largely quick And muster Data Tumminello Shareholder cast is for to us dates date companies cap percentage enough votes with quorum. meeting XX% was annual company that even me this their obtain this circumstances. is challenge on for firms
and holders so recall aggregate name However, on under banks, as long for in shares beneficial routine done the vote street discretionarily have those have client stock owners, and voting the exchange as other of record who in they I of the instructions discretionary rules, proposals from brokers authority past. absence can shares typically of in to
of fact, on such the However, shareholder proxy interpreting the by exercise for to and retail as for as holdings Charles for acquired get large may which affiliate, items. investors this XXXX customers Ameritrade when, shares [Indiscernible], exercise of Ascensia that this to Celsion, discretionary concentrating TD actually TD this at a Compounding to in this Rule the have Robinhood it's earlier to XX% year, a also policy a its in of real in routine the order had voting instructions. broker reach like discretionary retail practice to submitted Needless that Brokerage items declines discretionary absence vote in year, House. proxies estates federal problem, rule, held the prohibitive brokers customer were option, many discretionary same shares online a companies Schwab quorum. say, Ameritrade, of difficult declined its is vote matters with voted proportion
has we and bring making Your this brokers solution. from attention interpreting for properly. here? push starting with Perhaps do decided Celsion that sure XXXX has are company where problem to decided, So go Rule to
hopefully like with will with forward process also, We moving engagement practices. improve our to return that we'd individual plan are investors. in But the past their brokerages of to a
comprised to Society would as is proxy not bottom too be threshold by and investors participation have companies, first, also But the from part of and find Investor look. like working for ways is stock in engaged doing identify lobbyist has we'll the parallel, interpretation a to discouraging. I offerings, As Celsion, of our can cut the the finger roles lower voted into a authority auditors apps quorum, improve on affirmatively our strategy, have language Relations not and this. well that to such the as to National In constitutes Governance, via to are voting need way phone use of proxy the interpretation is challenge. we governance, this and exchange extraordinary will certainly means between plate the forced a Secretaries. firms, service for for including easy. much Corporate lack new for an on the you may the spending be adversely Finding to the correct which to been because contact who up grassroot engagement in create investigating various what bureaucracy as who administrative clarify the so. We're do tell who issuers, solicitors. a by to I'd retail Institute is the law direct which solicitation through We'll organizations. the doing this. The step banks, we're of we should investment supports pointing It's aside of including impacted line, many parties time. investors. money But time say We're there with to In from Corporate be is
central is on. As you what know, are corporate And governance. investors not let's sight lose X tenant share of X vote of voting
health We to therapeutics. impress As advance oftentimes, is our of passionate proxy facilitate investors impact upon disinterest proposals necessary about this are future company's success. human may to them as we their and that value the life-saving work initiative. Celsion development
Jeff. now, So to to call turn with I'd the that, over like Jeff?
